tiprankstipranks
Advertisement
Advertisement

TuHURA Biosciences Receives Nasdaq Minimum Bid Price Notice

Story Highlights
  • TuHURA Biosciences fell out of Nasdaq compliance on January 29, 2026 over its sub-$1 share price.
  • The company has until July 28, 2026, with possible extension, to lift its stock above $1 and avoid potential delisting.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
TuHURA Biosciences Receives Nasdaq Minimum Bid Price Notice

Claim 55% Off TipRanks

The latest update is out from TuHURA Biosciences ( (HURA) ).

On January 29, 2026, TuHURA Biosciences disclosed that it had received a notice from Nasdaq stating that its common stock had closed below $1.00 per share for 35 consecutive business days as of January 28, 2026, placing the company out of compliance with the exchange’s minimum bid price rule for continued listing. The company has been granted an initial 180-calendar day grace period, until July 28, 2026, to restore compliance by maintaining a closing bid price of at least $1.00 for a minimum of ten consecutive business days, with the possibility of an additional 180-day extension if certain other listing criteria are met and, if needed, a reverse stock split is pursued. While the notice does not immediately affect trading or SEC reporting requirements, continued non-compliance could ultimately lead to delisting proceedings, adding pressure on management to stabilize the share price and preserve the company’s Nasdaq listing status.

The most recent analyst rating on (HURA) stock is a Hold with a $0.54 price target. To see the full list of analyst forecasts on TuHURA Biosciences stock, see the HURA Stock Forecast page.

Spark’s Take on HURA Stock

According to Spark, TipRanks’ AI Analyst, HURA is a Neutral.

The score is primarily constrained by weak financial performance (pre-revenue, ongoing losses, and rising cash burn) and bearish technicals (below major moving averages with negative MACD). Corporate events provide a modest offset via added financing and pipeline/strategic progress, while valuation signals are limited due to a negative P/E and no dividend.

To see Spark’s full report on HURA stock, click here.

More about TuHURA Biosciences

TuHURA Biosciences, Inc. is a publicly traded biotechnology company whose shares are listed on The Nasdaq Capital Market, making it subject to Nasdaq’s continued listing standards, including minimum bid price requirements.

Average Trading Volume: 366,652

Technical Sentiment Signal: Sell

Current Market Cap: $34.51M

Find detailed analytics on HURA stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1